Florian Lordick, Oncologist, Professor of Medicine at the University of Leipzig, Head of Medical Oncology, Director of the Comprehensive Cancer Center Central Germany, shared a post on LinkedIn:
“A Highlight of ESMO – European Society for Medical Oncology Asia 2025: Symposium on the Future of Personalised Treatment in GI Cancer
One of the true highlights of ESMO Asia 2025 in Singapore was the outstanding symposium dedicated to the future of personalised treatment in gastrointestinal cancers. Expertly chaired by Dr. Lizzy Smyth (Oxford) and Dr. Nai-Jung Chang (Taipei), the session brought together leading international specialists sharing cutting-edge insights that are shaping the future of GI oncology.
Scientific Highlights Included:
- Personalised treatment of metastatic oesophagogastric tumours – Radka Lordick Obermannová (Brno)
- Biomarker-based approaches in hepatobiliary and pancreatic cancers – Changhoon Yoo (Seoul)
- Precision medicine in colorectal cancer treatment- Dominik Modest (Berlin)
- Molecular profiling: when to test and how to test- Tony Lim (Singapore)
The session combined state-of-the-art science, practical clinical perspectives, and visionary thinking on how personalised strategies can revolutionise care across the GI cancer spectrum. A truly energising and insightful discussion—without question one of the standout moments of the congress.”
More posts from ESMO Asia Congress 2025.